Emergent Biosolutions - Stock Price History | EBS

Historical daily share price chart and data for Emergent Biosolutions since 2021 adjusted for splits. The latest closing stock price for Emergent Biosolutions as of September 16, 2021 is 57.47.
  • The all-time high Emergent Biosolutions stock closing price was 134.94 on August 13, 2020.
  • The Emergent Biosolutions 52-week high stock price is 127.20, which is 121.3% above the current share price.
  • The Emergent Biosolutions 52-week low stock price is 55.07, which is 4.2% below the current share price.
  • The average Emergent Biosolutions stock price for the last 52 weeks is 81.37.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Emergent Biosolutions Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 83.1653 54.0000 134.9400 49.3400 89.6000 66.08%
2019 51.8647 57.7000 66.1600 39.9200 53.9500 -8.99%
2018 56.2235 47.9700 73.2400 44.4400 59.2800 27.57%
2017 34.9138 33.2300 47.7500 28.3000 46.4700 41.50%
2016 33.3817 38.0900 44.2200 24.6000 32.8400 -17.92%
2015 31.9165 26.9000 40.2800 26.2300 40.0100 46.93%
2014 23.8045 24.0200 28.0900 19.9200 27.2300 18.44%
2013 17.2350 16.9000 23.9500 13.0800 22.9900 43.33%
2012 15.0918 17.0000 18.3400 12.9100 16.0400 -4.75%
2011 20.4083 23.7800 24.9800 15.0200 16.8400 -28.22%
2010 17.0443 13.8100 23.8000 13.4600 23.4600 72.63%
2009 15.8787 25.0900 26.2600 9.6200 13.5900 -47.95%
2008 12.3571 5.0900 26.1100 4.9900 26.1100 416.01%
2007 10.3642 11.3000 16.9800 4.7100 5.0600 -54.66%
2006 10.8245 11.7000 11.7000 9.7700 11.1600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.069B $1.555B
Emergent BioSolutions Inc. is strongly committed to the highest standards of ethical conduct and corporate governance. These standards are consistent with their corporate culture. The company understands that adhering to sound principles of corporate governance is critical to earning and maintaining the trust of their customers, employees and shareholders. The foundation of the corporate governance principles and practices are built on their reputation for openness, integrity and accountability. These are the principles that guide Emergent BioSolutions everyday. They have in place policies and practices to ensure that their Company is managed with integrity and in their shareholders' best interests. In addition, they are committed to meeting the requirements of federal and state law and the rules of the New York Stock Exchange.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $175.368B 54.17
Bristol Myers Squibb (BMY) United States $137.771B 9.17
Amgen (AMGN) United States $123.866B 13.41
CSL (CSLLY) Australia $102.597B 0.00
Gilead Sciences (GILD) United States $89.973B 8.70
BioNTech SE (BNTX) Germany $86.154B 18.59
Regeneron Pharmaceuticals (REGN) United States $69.735B 11.97
Illumina (ILMN) United States $65.997B 74.98
Vertex Pharmaceuticals (VRTX) United States $48.996B 19.04
Biogen (BIIB) United States $44.592B 12.24
BeiGene (BGNE) Cayman Islands $34.845B 0.00
Genmab (GMAB) Denmark $28.151B 69.13
Seagen (SGEN) United States $27.670B 46.65
Genmab (GNMSF) Denmark $27.591B 68.97
Horizon Therapeutics Public (HZNP) Ireland $23.961B 22.71
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
Alnylam Pharmaceuticals (ALNY) United States $22.282B 0.00
Bio-Techne Corp (TECH) United States $20.698B 93.08
Exact Sciences (EXAS) United States $17.994B 0.00
Novavax (NVAX) United States $17.303B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.550B 0.00
Repligen (RGEN) United States $16.274B 124.02
Incyte (INCY) United States $16.218B 38.45
BioMarin Pharmaceutical (BMRN) United States $14.168B 101.67
Guardant Health (GH) United States $12.865B 0.00
QIAGEN (QGEN) Netherlands $12.195B 20.65
Zai Lab (ZLAB) China $11.901B 0.00
Intellia Therapeutics (NTLA) United States $11.055B 0.00
CureVac (CVAC) Germany $10.540B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $8.935B 22.95
Biohaven Pharmaceutical Holding (BHVN) United States $8.894B 0.00
Ascendis Pharma (ASND) Denmark $8.873B 0.00
Mirati Therapeutics (MRTX) United States $8.677B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $8.417B 30.17
Acceleron Pharma (XLRN) United States $8.170B 0.00
Vir Biotechnology (VIR) United States $6.832B 0.00
Beam Therapeutics (BEAM) United States $6.775B 0.00
Sarepta Therapeutics (SRPT) United States $6.711B 0.00
Ultragenyx Pharmaceutical (RARE) United States $6.580B 0.00
Exelixis (EXEL) United States $6.449B 70.59
Denali Therapeutics (DNLI) United States $6.402B 181.48
Fate Therapeutics (FATE) United States $6.330B 0.00
Blueprint Medicines (BPMC) United States $6.076B 17.15
Halozyme Therapeutics (HALO) United States $5.871B 23.98
Legend Biotech (LEGN) United States $5.871B 0.00
NeoGenomics (NEO) United States $5.802B 786.33
Twist Bioscience (TWST) United States $5.568B 0.00
Certara (CERT) United States $5.524B 0.00
I-Mab (IMAB) China $5.243B 0.00
AbCellera Biologics (ABCL) $5.242B 0.00
Adaptive Biotechnologies (ADPT) United States $5.153B 0.00
Alkermes (ALKS) Ireland $4.951B 146.14
Arvinas (ARVN) United States $4.668B 0.00
Editas Medicine (EDIT) United States $4.116B 0.00
Reata Pharmaceuticals (RETA) United States $3.859B 0.00
Galapagos (GLPG) Belgium $3.634B 0.00
Arena Pharmaceuticals (ARNA) United States $3.609B 0.00
SpringWorks Therapeutics (SWTX) United States $3.544B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $3.470B 0.00
Kymera Therapeutics (KYMR) United States $3.317B 0.00
Prothena (PRTA) Ireland $3.305B 0.00
Insmed (INSM) United States $3.185B 0.00
ALX Oncology Holdings (ALXO) United States $3.154B 0.00
Amicus Therapeutics (FOLD) United States $2.969B 0.00
Apellis Pharmaceuticals (APLS) United States $2.951B 0.00
Cytokinetics (CYTK) United States $2.814B 0.00
Intra-Cellular Therapies (ITCI) United States $2.723B 0.00
Heska (HSKA) United States $2.701B 517.80
ACADIA Pharmaceuticals (ACAD) United States $2.554B 0.00
Myriad Genetics (MYGN) United States $2.554B 0.00
Seer (SEER) $2.493B 0.00
Instil Bio (TIL) United States $2.476B 0.00
Celldex Therapeutics (CLDX) United States $2.473B 0.00
Morphic Holding (MORF) United States $2.442B 0.00
Arcus Biosciences (RCUS) United States $2.382B 0.00
Vericel (VCEL) United States $2.378B 283.33
Sorrento Therapeutics (SRNE) United States $2.367B 0.00
C4 Therapeutics (CCCC) United States $2.364B 0.00
Ligand Pharmaceuticals (LGND) United States $2.266B 33.14
Protagonist Therapeutics (PTGX) United States $2.210B 0.00
Atea Pharmaceuticals (AVIR) United States $2.151B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.072B 35.29
Amarin (AMRN) Ireland $2.040B 516.00
Myovant Sciences (MYOV) United Kingdom $2.010B 0.00
NGM Biopharmaceuticals (NGM) United States $1.983B 0.00
Alector (ALEC) United States $1.962B 0.00
REGENXBIO (RGNX) United States $1.924B 0.00
Revance Therapeutics (RVNC) United States $1.905B 0.00
Castle Biosciences (CSTL) United States $1.881B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.830B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.802B 0.00
Berkeley Lights (BLI) United States $1.786B 0.00
PHARMA MAR SA (PHMMF) Spain $1.737B 0.00
UniQure (QURE) Netherlands $1.676B 5.70
MorphoSys AG (MOR) Germany $1.671B 0.00
Dynavax Technologies (DVAX) United States $1.662B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.649B 0.00
Global Blood Therapeutics (GBT) United States $1.621B 0.00
Nurix Therapeutics (NRIX) United States $1.616B 0.00
Codexis (CDXS) United States $1.600B 0.00
Inovio Pharmaceuticals (INO) United States $1.592B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.563B 0.00
MaxCyte (MXCT) United States $1.541B 0.00
Zymeworks (ZYME) Canada $1.532B 0.00
Kadmon Holdings (KDMN) United States $1.517B 0.00
Ocugen (OCGN) United States $1.497B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.475B 0.00
Bionano Genomics (BNGO) United States $1.474B 0.00
Travere Therapeutics (TVTX) United States $1.429B 0.00
Genetron Holdings (GTH) China $1.420B 0.00
PureTech Health (PRTC) United States $1.418B 0.00
Zealand Pharma (ZEAL) Denmark $1.398B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.393B 0.00
Scholar Rock Holding (SRRK) United States $1.380B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.377B 0.00
Inhibrx (INBX) United States $1.372B 0.00
Sangamo Therapeutics (SGMO) United States $1.331B 0.00
Agenus (AGEN) United States $1.253B 0.00
BioAtla (BCAB) United States $1.246B 0.00
Coherus BioSciences (CHRS) United States $1.208B 0.00
Bluebird Bio (BLUE) United States $1.203B 0.00
Avid Bioservices (CDMO) United States $1.169B 238.13
MannKind (MNKD) United States $1.166B 0.00
Repare Therapeutics (RPTX) Canada $1.143B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.143B 0.00
Precigen (PGEN) United States $1.130B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.117B 0.00
RAPT THERAPTICS (RAPT) United States $1.105B 0.00
Fulcrum Therapeutics (FULC) United States $1.087B 0.00
Northwest Biotherapeutics (NWBO) United States $1.075B 0.00
ImmunityBio (IBRX) United States $1.046B 0.00
IDEAYA Biosciences (IDYA) United States $1.002B 0.00
Zealand Pharma (ZLDPF) Denmark $0.997B 0.00
Merus (MRUS) Netherlands $0.983B 0.00
Nkarta (NKTX) United States $0.968B 0.00
Prometheus Biosciences (RXDX) United States $0.949B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.941B 0.00
Sutro Biopharma (STRO) United States $0.922B 0.00
Immatics (IMTX) Germany $0.920B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.909B 28.17
BeyondSpring (BYSI) United States $0.898B 0.00
Avidity Biosciences (RNA) United States $0.862B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.843B 0.00
Shattuck Labs (STTK) United States $0.842B 0.00
Mesoblast (MESO) Australia $0.824B 0.00
VBI Vaccines (VBIV) United States $0.809B 0.00
Curis (CRIS) United States $0.765B 0.00
Precision BioSciences (DTIL) United States $0.741B 0.00
Cara Therapeutics (CARA) United States $0.740B 92.31
Keros Therapeutics (KROS) United States $0.728B 0.00
Amryt Pharma (AMYT) United Kingdom $0.717B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.711B 0.00
AnaptysBio (ANAB) United States $0.709B 0.00
Pliant Therapeutics (PLRX) United States $0.677B 0.00
Adagene (ADAG) China $0.665B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.656B 11.95
Mersana Therapeutics (MRSN) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Cellectis S.A (CLLS) France $0.636B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.633B 0.00
Gritstone Bio (GRTS) United States $0.632B 0.00
Ambrx Biopharma (AMAM) United States $0.629B 0.00
Pharming Group (PHAR) Netherlands $0.627B 0.00
MiMedx (MDXG) United States $0.626B 0.00
Affimed (AFMD) Germany $0.622B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.620B 0.00
Akoya Biosciences (AKYA) United States $0.617B 0.00
Pharming Group (PHGUF) Netherlands $0.612B 24.44
Spero Therapeutics (SPRO) United States $0.596B 0.00
Bolt Biotherapeutics (BOLT) United States $0.595B 0.00
G1 THERAPEUTICS (GTHX) United States $0.590B 0.00
Seres Therapeutics (MCRB) United States $0.582B 0.00
Anika Therapeutics (ANIK) United States $0.574B 0.00
DBV Technologies S.A (DBVT) France $0.573B 0.00
MeiraGTx Holdings (MGTX) United States $0.569B 0.00
VistaGen Therapeutics (VTGN) United States $0.563B 0.00
ALBIREO PHARMA (ALBO) United States $0.563B 0.00
Vaccitech (VACC) United Kingdom $0.553B 0.00
Epizyme (EPZM) United States $0.550B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.527B 0.00
Clovis Oncology (CLVS) United States $0.527B 0.00
Inventiva S.A (IVA) France $0.522B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.501B 0.00
AC Immune SA (ACIU) Switzerland $0.495B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Selecta Biosciences (SELB) United States $0.491B 0.00
Cel-Sci (CVM) United States $0.481B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.480B 0.00
XBiotech (XBIT) United States $0.479B 0.00
Verastem (VSTM) United States $0.461B 0.00
Clene (CLNN) United States $0.457B 0.00
ChromaDex (CDXC) United States $0.455B 0.00
Bellus Health (BLU) Canada $0.454B 0.00
Innate Pharma S.A (IPHA) France $0.442B 0.00
Geron (GERN) United States $0.436B 0.00
Oncobiologics (OTLK) United States $0.424B 0.00
Compugen (CGEN) Israel $0.419B 0.00
Arbutus Biopharma (ABUS) United States $0.418B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.415B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.415B 0.00
BioDelivery Sciences (BDSI) United States $0.410B 12.61
Codiak BioSciences (CDAK) United States $0.403B 0.00
SQZ Biotechnologies (SQZ) United States $0.398B 0.00
Clearside Biomedical (CLSD) United States $0.391B 0.00
Starpharma Holdings (SPHRY) Australia $0.390B 0.00
Cue Biopharma (CUE) United States $0.382B 0.00
KaloBios Pharmaceuticals (HGEN) United States $0.381B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.371B 0.00
Athenex (ATNX) United States $0.371B 0.00
Cybin (CYBN) Canada $0.368B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.364B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.364B 0.00
ANI Pharmaceuticals (ANIP) United States $0.350B 9.54
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
Theratechnologies (THTX) Canada $0.342B 0.00
Neoleukin Therapeutics (NLTX) United States $0.341B 0.00
Opthea (OPT) Australia $0.338B 0.00
Fortress Biotech (FBIO) United States $0.335B 0.00
Athersys (ATHX) United States $0.333B 0.00
Prima BioMed (IMMP) Australia $0.327B 0.00
Cogent Biosciences (COGT) United States $0.325B 0.00
Syros Pharmaceuticals (SYRS) United States $0.325B 0.00
CytomX Therapeutics (CTMX) United States $0.324B 0.00
Angion Biomedica (ANGN) United States $0.319B 0.00
INmune Bio (INMB) United States $0.312B 0.00
AquaBounty Technologies (AQB) United States $0.298B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.290B 0.00
Puma Biotechnology (PBYI) United States $0.284B 0.00
WAVE Life Sciences (WVE) Singapore $0.281B 0.00
XOMA (XOMA) United States $0.275B 115.81
Beyond Air (XAIR) United States $0.272B 0.00
Checkpoint Therapeutics (CKPT) United States $0.262B 0.00
Cardiff Oncology (CRDF) United States $0.259B 0.00
IBio (IBIO) United States $0.244B 0.00
Frequency Therapeutics (FREQ) United States $0.243B 0.00
Kamada (KMDA) Israel $0.239B 19.85
OVID THERAPEUTC (OVID) United States $0.235B 2.06
Paratek Pharmaceuticals (PRTK) United States $0.232B 0.00
Kaleido Biosciences (KLDO) $0.229B 0.00
Adicet Bio (ACET) United States $0.225B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.224B 0.00
Adverum Biotechnologies (ADVM) United States $0.213B 0.00
Seelos Therapeutics (SEEL) United States $0.203B 0.00
NextCure (NXTC) United States $0.201B 0.00
Trevena (TRVN) United States $0.201B 0.00
Kala Pharmaceuticals (KALA) United States $0.200B 0.00
Talis Biomedical (TLIS) United States $0.193B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
SESEN BIO, INC (SESN) United States $0.183B 0.00
TELA Bio (TELA) United States $0.181B 0.00
ObsEva SA (OBSV) Switzerland $0.176B 0.00
CorMedix Inc (CRMD) United States $0.176B 0.00
GENFIT S.A (GNFT) France $0.173B 0.00
VolitionRX (VNRX) United States $0.170B 0.00
Synlogic (SYBX) United States $0.166B 0.00
Enzo Biochem (ENZ) United States $0.165B 48.57
TScan Therapeutics (TCRX) United States $0.165B 0.00
HOOKIPA Pharma (HOOK) United States $0.164B 0.00
Aptinyx (APTX) United States $0.163B 0.00
POXEL SA FRANCE (PXXLF) France $0.161B 0.00
Galena Biopharma (SLS) United States $0.160B 0.00
ADMA Biologics Inc (ADMA) United States $0.159B 0.00
Catalyst Biosciences (CBIO) United States $0.159B 0.00
Erytech Pharma SA (ERYP) France $0.157B 0.00
LogicBio Therapeutics (LOGC) United States $0.146B 0.00
Dyadic (DYAI) United States $0.146B 0.00
Biofrontera AG (BFRA) Germany $0.145B 0.00
Vascular Biogenics (VBLT) Israel $0.145B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.145B 0.00
ATyr Pharma (LIFE) United States $0.144B 0.00
VTv Therapeutics (VTVT) United States $0.144B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 0.00
Nicox SA (NICXF) France $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.141B 0.00
Applied Genetic Technologies (AGTC) United States $0.139B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
Novogen (KZIA) Australia $0.135B 0.00
Purple Biotech (PPBT) Israel $0.129B 0.00
Cyclerion Therapeutics (CYCN) United States $0.127B 0.00
Abeona Therapeutics (ABEO) United States $0.126B 0.00
Evofem Biosciences (EVFM) United States $0.123B 0.00
Eton Pharmaceuticals (ETON) United States $0.123B 0.00
Orgenesis (ORGS) United States $0.122B 248.00
X4 Pharmaceuticals (XFOR) United States $0.119B 0.00
Exicure (XCUR) United States $0.119B 0.00
Yumanity Therapeutics (YMTX) United States $0.118B 0.00
Eyenovia (EYEN) United States $0.116B 0.00
Leap Therapeutics (LPTX) United States $0.115B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.115B 0.00
Voyager Therapeutics (VYGR) United States $0.114B 6.54
Viridian Therapeutics (VRDN) United States $0.114B 0.00
Entera Bio (ENTX) Israel $0.109B 0.00
Palatin Technologies (PTN) United States $0.108B 0.00
Cidara Therapeutics (CDTX) United States $0.103B 0.00
Cocrystal Pharma (COCP) United States $0.103B 0.00
Armata Pharmaceuticals (ARMP) United States $0.097B 0.00
Pluristem Therapeutics (PSTI) Israel $0.095B 0.00
Aadi Bioscience (AADI) United States $0.090B 0.00
Celsion (CLSN) United States $0.089B 0.00
Lumos Pharma (LUMO) United States $0.088B 0.00
Aptevo Therapeutics (APVO) United States $0.084B 0.00
Adocia (ADOCY) France $0.083B 0.00
ARAVIVE, INC (ARAV) United States $0.081B 0.00
Zosano Pharma (ZSAN) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.080B 0.00
Advaxis (ADXS) United States $0.080B 0.00
Liminal BioSciences (LMNL) Canada $0.078B 0.00
Aytu BioPharma (AYTU) United States $0.077B 0.00
AEterna Zentaris (AEZS) United States $0.075B 0.00
TRACON Pharmaceuticals (TCON) United States $0.074B 0.00
DiaMedica Therapeutics (DMAC) United States $0.073B 0.00
Edesa Biotech (EDSA) Canada $0.072B 0.00
Emmaus Life Sciences (EMMA) United States $0.071B 0.00
Evogene (EVGN) Israel $0.071B 0.00
Longeveron (LGVN) United States $0.070B 0.00
Celyad SA (CYAD) Belgium $0.069B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Vyant Bio (VYNT) United States $0.069B 0.00
AIkido Pharma (AIKI) United States $0.068B 0.00
ABVC BioPharma (ABVC) United States $0.067B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
Protalix BioTherapeutics (PLX) Israel $0.061B 0.00
Enveric Biosciences (ENVB) United States $0.057B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.055B 0.00
Idera Pharmaceuticals (IDRA) United States $0.054B 0.00
AnPac Bio-Medical Science (ANPC) China $0.053B 0.00
Acorda Therapeutics (ACOR) United States $0.052B 1.08
Genetic Technologies (GENE) Australia $0.052B 0.00
Statera Biopharma (STAB) United States $0.050B 0.00
Vallon Pharmaceuticals (VLON) United States $0.049B 0.00
Forte Biosciences (FBRX) United States $0.049B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
ARIDIS PHARMACT (ARDS) United States $0.048B 0.00
BioCardia (BCDA) United States $0.048B 0.00
Soligenix (SNGX) United States $0.044B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Cyclo Therapeutics (CYTH) United States $0.042B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.038B 0.00
Alimera Sciences (ALIM) United States $0.038B 0.00
Invo BioScience (INVO) United States $0.037B 0.00
Palisade Bio (PALI) United States $0.036B 0.00
Happiness Biotech Group (HAPP) China $0.035B 0.00
Timber Pharmaceuticals (TMBR) United States $0.033B 0.00
Lexaria Bioscience (LEXX) Canada $0.032B 0.00
ZIVO Bioscience (ZIVO) United States $0.031B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
Prana Biotechnology (ATHE) Australia $0.029B 0.00
GeoVax Labs (GOVX) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
ThermoGenesis Holdings (THMO) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.016B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
UROGEN PHARMA (URGN) United States $0.000B 0.00